Abstract
Background:
The fat mass- and obesity-associated (FTO) gene influences energy homeostasis in humans. Although the obesity-related variant, rs9939609 has been replicated across a number of cohort studies, there remains significant variance and a low to modest association. Telomere length is another commonly reported obesity risk factor. We hypothesize understanding the associations between FTO rs9939609 with FTO methylation and telomere length will provide a more accurate assessment of obesity risk.
Methods:
Overall, 942 participants free of diabetes or pre-diabetes were included in the retrospective study. Leukocyte genomic DNA was analyzed for rs9939609 genotyping, FTO gene methylation and leukocyte telomere length (LTL) measurement.
Results:
In general linear models, rs9939609 AA genotypes were associated with increased fat percentage (3.15%, P=0.001), fat mass (4.16 kg, P=0.001), body mass index (BMI) (1.38, P=0.006) and waist circumference (3.35 cm, P=0.006), but not with FTO methylation or LTL in this overall population. However, when participants were stratified into higher and lower FTO methylation groups, the AA genotype possesses a 2.04-fold increased obesity risk in comparison to TT genotype (95%CI, 1.07-3.89, P=0.031) in participants with a higher FTO methylation level, but this association was absent in the lower FTO methylation sub-group. Moreover, AT and AA genotype carriers were associated with shorter LTL compared to TT carriers (P=0.020 and P=0.111, respectively) in the higher FTO methylation level group. However, this association was absent in the lower methylation group. Furthermore, FTO gene methylation level was significantly associated with LTL in the 942 samples (P=0.017).
Conclusions:
FTO rs9939609 is associated with obesity risk and LTL in this study, where this association is only observed at higher, but not lower, FTO methylation levels of participants. Our data suggest association of multiple factors, including FTO methylation level, may be involved in one of several mechanisms underlying the commonly reported obesity risk of this FTO polymorphism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 2007; 39: 724–726.
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889–894.
Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007; 3: e115.
Li H, Wu Y, Loos RJ, Hu FB, Liu Y, Wang J et al. Variants in the fat mass- and obesity-associated (FTO) gene are not associated with obesity in a Chinese Han population. Diabetes 2008; 57: 264–268.
Loos RJ, Bouchard C . FTO: the first gene contributing to common forms of human obesity. Obes Rev 2008; 9: 246–250.
den Hoed M, Westerterp-Plantenga MS, Bouwman FG, Mariman EC, Westerterp KR . Postprandial responses in hunger and satiety are associated with the rs9939609 single nucleotide polymorphism in FTO. Am J Clin Nutr 2009; 90: 1426–1432.
Olszewski PK, Fredriksson R, Olszewska AM, Stephansson O, Alsio J, Radomska KJ et al. Hypothalamic FTO is associated with the regulation of energy intake not feeding reward. BMC Neurosci 2009; 10: 129.
Qi Q, Downer MK, Kilpelainen TO, Taal HR, Barton SJ, Ntalla I et al. Dietary intake, FTO genetic variants, and adiposity: a combined analysis of over 16,000 children and adolescents. Diabetes 2015; 64: 2467–2476.
Labayen I, Ruiz JR, Ortega FB, Dallongeville J, Jimenez-Pavon D, Castillo MJ et al. Association between the FTO rs9939609 polymorphism and leptin in European adolescents: a possible link with energy balance control. The HELENA study. Int J Obes 2011; 35: 66–71.
Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007; 318: 1469–1472.
Jia G, Yang CG, Yang S, Jian X, Yi C, Zhou Z et al. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett 2008; 582: 3313–3319.
Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 2011; 7: 885–887.
Mulligan CJ, D'Errico NC, Stees J, Hughes DA . Methylation changes at NR3C1 in newborns associate with maternal prenatal stress exposure and newborn birth weight. Epigenetics 2012; 7: 853–857.
Garcia-Lacarte M, Milagro FI, Zulet MA, Martinez JA, Mansego ML . LINE-1 methylation levels, a biomarker of weight loss in obese subjects, are influenced by dietary antioxidant capacity. Redox Rep 2016; 21: 67–74.
Guenard F, Deshaies Y, Hould F, Lebel S, Tchernof A, Marceau P et al. Use of blood as a surrogate model for the assessment of visceral adipose tissue methylation progiles associated with the metabolic syndrome in men. J Mol Genet Med 2016; 10: 1.
Bacos K, Gillberg L, Volkov P, Olsson AH, Hansen T, Pedersen O et al. Blood-based biomarkers of age-associated epigenetic changes in human islets associate with insulin secretion and diabetes. Nat Commun 2016; 7: 11089.
Esterbauer H, Schneitler C, Oberkofler H, Ebenbichler C, Paulweber B, Sandhofer F et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 2001; 28: 178–183.
Salpea KD, Talmud PJ, Cooper JA, Maubaret CG, Stephens JW, Abelak K et al. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010; 209: 42–50.
Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 2012; 21: 371–383.
Zhao J, Goldberg J, Bremner JD, Vaccarino V . Global DNA methylation is associated with insulin resistance: a monozygotic twin study. Diabetes 2012; 61: 542–546.
Stefan M, Zhang W, Concepcion E, Yi Z, Tomer Y . DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology. J Autoimmun 2014; 50: 33–37.
Houben JM, Moonen HJ, van Schooten FJ, Hageman GJ . Telomere length assessment: biomarker of chronic oxidative stress? Free Radical Biol Med 2008; 44: 235–246.
Fernandez-Sanchez A, Madrigal-Santillan E, Bautista M, Esquivel-Soto J, Morales-Gonzalez A, Esquivel-Chirino C et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci 2011; 12: 3117–3132.
An R, Yan H . Body weight status and telomere length in US middle-aged and older adults. Obes Res Clin Pract 2016; 11: 51–62.
Chen S, Yeh F, Lin J, Matsuguchi T, Blackburn E, Lee ET et al. Short leukocyte telomere length is associated with obesity in American Indians: the Strong Heart Family study. Aging 2014; 6: 380–389.
Njajou OT, Cawthon RM, Blackburn EH, Harris TB, Li R, Sanders JL et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes 2012; 36: 1176–1179.
Shin C, Kim NH, Baik I . Sex-specific association between longitudinal changes in adiposity, FTO rs9939609 polymorphism, and leukocyte telomere length. J Am Coll Nutr 2016; 35: 245–254.
Devers MC, Campbell S, Shaw J, Zimmet P, Simmons D . Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease. Diabet Med 2008; 25: 523–529.
American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015; 38 Suppl: S8–S16.
[No authors listed]. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: 1–253.
[No authors listed]. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Obes Res 1998; 6 Suppl 2: 51S–209S.
Yu D, Simmons D . Association between lung capacity measurements and abnormal glucose metabolism: findings from the Crossroads study. Diabet Med 2014; 31: 595–599.
Cawthon RM . Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009; 37: e21.
Hunt SC, Stone S, Xin Y, Scherer CA, Magness CL, Iadonato SP et al. Association of the FTO gene with BMI. Obesity 2008; 16: 902–904.
Li H, Kilpelainen TO, Liu C, Zhu J, Liu Y, Hu C et al. Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 2012; 55: 981–995.
Andreasen CH, Stender-Petersen KL, Mogensen MS, Torekov SS, Wegner L, Andersen G et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 2008; 57: 95–101.
Cohen-Cline H, Lau R, Moudon AV, Turkheimer E, Duncan GE . Associations between fast-food consumption and body mass index: a cross-sectional study in adult twins. Twin Res Hum Genet 2015; 18: 375–382.
Loos RJ, Yeo GS . The bigger picture of FTO: the first GWAS-identified obesity gene. Nat Rev Endocrinol 2014; 10: 51–61.
Berulava T, Horsthemke B . The obesity-associated SNPs in intron 1 of the FTO gene affect primary transcript levels. Eur J Hum Genet 2010; 18: 1054–1056.
Jowett JB, Curran JE, Johnson MP, Carless MA, Goring HH, Dyer TD et al. Genetic variation at the FTO locus influences RBL2 gene expression. Diabetes 2010; 59: 726–732.
Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C et al. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 2015; 373: 895–907.
Almen MS, Jacobsson JA, Moschonis G, Benedict C, Chrousos GP, Fredriksson R et al. Genome wide analysis reveals association of a FTO gene variant with epigenetic changes. Genomics 2012; 99: 132–137.
Tan M, Wei C, Price CM . The telomeric protein Rap1 is conserved in vertebrates and is expressed from a bidirectional promoter positioned between the Rap1 and KARS genes. Gene 2003; 323: 1–10.
Johnston SD, Enomoto S, Schneper L, McClellan MC, Twu F, Montgomery ND et al. CAC3(MSI1) suppression of RAS2(G19V) is independent of chromatin assembly factor I and mediated by NPR1. Mol Cell Biol 2001; 21: 1784–1794.
Grandin N, Reed SI, Charbonneau M . Stn1, a new Saccharomyces cerevisiae protein, is implicated in telomere size regulation in association with Cdc13. Genes Dev 1997; 11: 512–527.
Grandin N, Damon C, Charbonneau M . Ten1 functions in telomere end protection and length regulation in association with Stn1 and Cdc13. EMBO J 2001; 20: 1173–1183.
Bai B, Liang Y, Xu C, Lee MY, Xu A, Wu D et al. Cyclin-dependent kinase 5-mediated hyperphosphorylation of sirtuin-1 contributes to the development of endothelial senescence and atherosclerosis. Circulation 2012; 126: 729–740.
Minegishi Y, Haramizu S, Misawa K, Shimotoyodome A, Hase T, Murase T . Deletion of nuclear factor-kappaB p50 upregulates fatty acid utilization and contributes to an anti-obesity and high-endurance phenotype in mice. Am J Physiol Endocrinol Metab 2015; 309: E523–E533.
Schubeler D . Function and information content of DNA methylation. Nature 2015; 517: 321–326.
Lay FD, Liu Y, Kelly TK, Witt H, Farnham PJ, Jones PA et al. The role of DNA methylation in directing the functional organization of the cancer epigenome. Genome Res 2015; 25: 467–477.
Church C, Moir L, McMurray F, Girard C, Banks GT, Teboul L et al. Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet 2010; 42: 1086–1092.
Mundstock E, Sarria EE, Zatti H, Mattos Louzada F, Kich Grun L, Herbert Jones M et al. Effect of obesity on telomere length: Systematic review and meta-analysis. Obesity 2015; 23: 2165–2174.
Zhao J, Zhu Y, Lin J, Matsuguchi T, Blackburn E, Zhang Y et al. Short leukocyte telomere length predicts risk of diabetes in American Indians: the strong heart family study. Diabetes 2014; 63: 354–362.
Demissie S, Levy D, Benjamin EJ, Cupples LA, Gardner JP, Herbert A et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging cell 2006; 5: 325–330.
Verhulst S, Dalgard C, Labat C, Kark JD, Kimura M, Christensen K et al. A short leucocyte telomere length is associated with development of insulin resistance. Diabetologia 2016; 59: 1258–1265.
Toperoff G, Kark JD, Aran D, Nassar H, Ahmad WA, Sinnreich R et al. Premature aging of leukocyte DNA methylation is associated with type 2 diabetes prevalence. Clin Epigenet 2015; 7: 35.
Sun Q, Shi L, Prescott J, Chiuve SE, Hu FB, De Vivo I et al. Healthy lifestyle and leukocyte telomere length in U.S. women. PLoS One 2012; 7: e38374.
Bekaert S, De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Langlois M et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell 2007; 6: 639–647.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Zhou, Y., Simmons, D., Lai, D. et al. rs9939609 FTO genotype associations with FTO methylation level influences body mass and telomere length in an Australian rural population. Int J Obes 41, 1427–1433 (2017). https://doi.org/10.1038/ijo.2017.127
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2017.127
This article is cited by
-
Modification of the association by sex between the prenatal exposure to di(2-ethylhexyl) phthalate and fat percentage in a cohort of Mexicans schoolchildren
International Journal of Obesity (2022)
-
FTO haplotyping underlines high obesity risk for European populations
BMC Medical Genomics (2019)
-
The impact of probiotic supplementation during pregnancy on DNA methylation of obesity-related genes in mothers and their children
European Journal of Nutrition (2019)
-
FTO associations with obesity and telomere length
Journal of Biomedical Science (2017)